F Searle

1.9k total citations
52 papers, 1.4k citations indexed

About

F Searle is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, F Searle has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Radiology, Nuclear Medicine and Imaging, 20 papers in Molecular Biology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in F Searle's work include Monoclonal and Polyclonal Antibodies Research (21 papers), Radiopharmaceutical Chemistry and Applications (19 papers) and Gestational Trophoblastic Disease Studies (12 papers). F Searle is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (21 papers), Radiopharmaceutical Chemistry and Applications (19 papers) and Gestational Trophoblastic Disease Studies (12 papers). F Searle collaborates with scholars based in United Kingdom and United States. F Searle's co-authors include K D Bagshawe, Pari Antoniw, RG Melton, R.F. Sherwood, Springer Cj, SK Sharma, Richard H. J. Beǵent, K. D. Bagshawe, G.T. Rogers and Ruth Duncan and has published in prestigious journals such as Nature, The Lancet and FEBS Letters.

In The Last Decade

F Searle

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Searle United Kingdom 19 767 685 334 186 164 52 1.4k
Kenneth D. Bagshawe United Kingdom 21 461 0.6× 570 0.8× 266 0.8× 181 1.0× 121 0.7× 44 1.3k
Pari Antoniw United Kingdom 15 659 0.9× 684 1.0× 281 0.8× 149 0.8× 174 1.1× 21 1.1k
M. V. Pimm United Kingdom 29 1.2k 1.6× 769 1.1× 682 2.0× 119 0.6× 272 1.7× 123 2.3k
G.T. Rogers United Kingdom 18 549 0.7× 506 0.7× 228 0.7× 121 0.7× 84 0.5× 53 960
Robert S. Greenfield United States 17 388 0.5× 480 0.7× 334 1.0× 169 0.9× 49 0.3× 43 1.3k
T. Ghose Canada 20 493 0.6× 350 0.5× 274 0.8× 66 0.4× 60 0.4× 55 1.1k
Vic Raso United States 13 296 0.4× 419 0.6× 350 1.0× 47 0.3× 159 1.0× 26 1.2k
Elaine Westrick United States 19 351 0.5× 937 1.4× 620 1.9× 370 2.0× 103 0.6× 28 2.2k
Nikki Parker United States 13 271 0.4× 702 1.0× 461 1.4× 217 1.2× 85 0.5× 16 1.7k
RG Melton United Kingdom 12 368 0.5× 414 0.6× 190 0.6× 134 0.7× 123 0.8× 17 748

Countries citing papers authored by F Searle

Since Specialization
Citations

This map shows the geographic impact of F Searle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Searle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Searle more than expected).

Fields of papers citing papers by F Searle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Searle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Searle. The network helps show where F Searle may publish in the future.

Co-authorship network of co-authors of F Searle

This figure shows the co-authorship network connecting the top 25 collaborators of F Searle. A scholar is included among the top collaborators of F Searle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Searle. F Searle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haviland, Miriam J., et al.. (2017). Opioid use following gynecologic and pelvic reconstructive surgery. International Urogynecology Journal. 29(10). 1441–1445. 25 indexed citations
2.
Pedone, Elisa, F Searle, & Steve Brocchini. (2006). Diethylstilbestrol glutamate as a potential substrate for ADEPT. Journal of drug targeting. 14(6). 437–443. 4 indexed citations
3.
Duncan, Ruth, et al.. (2001). Polymer–drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic. Journal of Controlled Release. 74(1-3). 135–146. 144 indexed citations
5.
Searle, F, et al.. (1996). Altered biodistribution of an antibody-enzyme conjugate modified with polyethylene glycol. British Journal of Cancer. 73(11). 1323–1327. 13 indexed citations
6.
Fisher, Rosemary A., et al.. (1992). 7 The immune system in disease: gestational trophoblastic tumours. Baillière s Clinical Obstetrics and Gynaecology. 6(3). 519–539. 1 indexed citations
7.
Springer, Caroline J., Kenneth D. Bagshawe, Surinder K. Sharma, et al.. (1991). Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds. European Journal of Cancer and Clinical Oncology. 27(11). 1361–1366. 86 indexed citations
8.
Philip, P. A., K. D. Bagshawe, F Searle, et al.. (1991). In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in man. British Journal of Cancer. 63(1). 134–135. 12 indexed citations
10.
Antoniw, Pari, Springer Cj, K D Bagshawe, et al.. (1990). Disposition of the prodrug 4-(bis (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in mice. British Journal of Cancer. 62(6). 909–914. 38 indexed citations
11.
Springer, Caroline J., et al.. (1990). Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2. Journal of Medicinal Chemistry. 33(2). 677–681. 100 indexed citations
12.
Begent, RHJ, et al.. (1990). Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetry. British Journal of Cancer. 61(2). 218–220. 9 indexed citations
13.
Begent, RHJ, JA Ledermann, K D Bagshawe, et al.. (1989). Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer. British Journal of Cancer. 60(3). 406–412. 50 indexed citations
14.
Heyderman, Robert S., et al.. (1989). Antibody Imaging to Locate a Placental Site Trophoblastic Tumour following a Complete Hydatidiform Mole. Journal of the Royal Society of Medicine. 82(5). 299–300. 5 indexed citations
15.
Ledermann, JA, et al.. (1988). Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A. British Journal of Cancer. 58(5). 654–657. 65 indexed citations
16.
Begent, RHJ, et al.. (1987). The clinical value of imaging with antibody to human chorionic gonadotrophin in the detection of residual choriocarcinoma. British Journal of Cancer. 55(6). 657–660. 17 indexed citations
18.
Bagshawe, K D, Mark N. Wass, & F Searle. (1980). Markers in gynaecological cancer. Archives of Gynecology and Obstetrics. 229(4). 303–310. 16 indexed citations
19.
Stone, Michael E., K. D. Bagshawe, A Kardana, F Searle, & J. Dent. (1977). β‐HUMAN CHORIONIC GONADOTROPHIN AND CARCINO‐EMBRYONIC ANTIGEN IN THE MANAGEMENT OF OVARIAN CARCINOMA. BJOG An International Journal of Obstetrics & Gynaecology. 84(5). 375–379. 19 indexed citations
20.
Rogers, G.T., et al.. (1977). Heterogeneity and specificity of circulating carcinoembryonic antigen. European Journal of Cancer (1965). 13(3). 293–295. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026